Phase
Condition
Common Cold
Allergy
Nasal Obstruction
Treatment
NEUROMARK System
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subject MUST:
Be ≥18 years of age.
Be scheduled to receive treatment with the commercially available NEUROMARK Systemconsistent with the device's indications for use.
Have moderate to severe symptoms of running nose (individual rTNSS symptom rating of 2 or 3), mild to severe symptoms of nasal congestion (individual rTNSS symptomrating of 1, 2, or 3), and a minimum total score of 5 (out of 12) at screening.
Be willing and able to provide consent and comply with all study elements, asindicated by written informed consent.
Exclusion
Exclusion Criteria:
Subjects Must Not:
- Have a history of chronic epistaxis or experienced a significant epistaxis event (defined as epistaxis requiring medical intervention) in the past 3 months.
Study Design
Connect with a study center
Alabama Nasal & Sinus Center
Birmingham, Alabama 35242
United StatesSite Not Available
Sensa Health
Los Angeles, California 90006
United StatesSite Not Available
Sacramento ENT
Roseville, California 95661
United StatesSite Not Available
Florida ENT & Allergy
Brandon, Florida 33511
United StatesSite Not Available
ENT & Allergy Texas
McKinney, Texas 75071
United StatesSite Not Available
Ogden Clinic
Ogden, Utah 84403
United StatesSite Not Available
Metropolitan ENT
Alexandria, Virginia 22310
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.